Monday November 23 2009 | Biotechnology feed | All feeds
|
|
AMS Biotechnology (Europe) Ltd
Download detailed PDF Members: ImmunoKontact (IK) is part of AMS Biotechnology (Europe) Ltd having been spun out in 1996 to create its own brand. Prior to this AMS was commercialising the Pharmingen product range. When Pharmingen was sold to Becton Dickenson, AMS found themselves with a significant market that could not be servicedIK established itself as a premier provider of cytokine reagents through licensing deals with Dynax for the mouse cytokine antibodies of John Abrams and by adding agreements with the Basel Institute and Novartis. From 1997 through to the end of 2001, the range grew to include human and mouse CDs, TCR markers and reagents for studying Apoptosis. At the start of 2002 IK offered over 3000 individual products
This page has been viewed 281 times since April 2007, the link to the organisation's website has been followed 57 times Search for more companies in Abingdon Search for more companies in Oxfordshire This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for AMS Biotechnology (Europe) Ltd | ||||||||||||||||||||||||||
|